Insulet | PODD - Le Coût Des Ventes

Prix De L'Action
228.63
Variation Quotidienne
-1.65 -0.72%
Mensuellement
-5.48%
Annuel
-13.85%
Q1 Prévisions
213.20




Le Coût Des Ventes Changement Date
Abbott USD 4.92B 535M 2025-12
Align Technology USD 363.97M 7.48M 2025-12
AtriCure USD 35.16M 2.23M 2025-12
Avanos Medical USD 94.9M 3.1M 2025-12
Baxter International USD 2.4B 512M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Boston Scientific USD 1.84B 82M 2025-12
Cardinal Health USD 63.36B 1.57B 2025-12
Cooper Companies USD 376.8M 87.4M 2025-12
Dexcom USD 466.9M 11M 2025-12
Edwards Lifesciences USD 343M 2.2M 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Globus Medical USD 290.47M 8.09M 2025-12
ICU Medical USD 337.72M 1.61M 2025-12
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 215.2M 19M 2025-12
Integra LifeSciences USD 193.44M 1.62M 2025-12
J&J USD 7.97B 689M 2025-12
Masimo USD 165.2M 24.3M 2025-12
Medtronic USD 3.61B 83M 2025-12
Merit Medical Systems USD 198.58M 838K 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Solventum Corp USD 971M 8M 2025-12
Stryker USD 2.69B 373M 2025-12
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 261.54M 199.84M 2025-12
West Pharmaceutical Services USD 501.1M 9.2M 2025-12
Zimmer Biomet Holdings USD 970.1M 234.3M 2025-12